Viewing StudyNCT01585233



Ignite Creation Date: 2024-05-06 @ 12:29 AM
Last Modification Date: 2024-10-26 @ 10:50 AM
Study NCT ID: NCT01585233
Status: COMPLETED
Last Update Posted: 2024-03-05
First Post: 2012-04-24

Brief Title: A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis
Sponsor: Astellas Pharma Global Development Inc
Organization: Astellas Pharma Inc

Conditions & Keywords Data

Conditions:
Name
Psoriasis
Keywords:
Name View
Anti-CD40 monoclonal antibody View
Moderate Psoriasis View
Severe Psoriasis View
Skin disease View
ASKP1240 View
CD40 antigen View